Sphingoid Bases Regulate the Sigma-1 Receptor—Sphingosine and N,N’-Dimethylsphingosine Are Endogenous Agonists
暂无分享,去创建一个
[1] Hongji Sun,et al. The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment , 2022, Frontiers in Neuroscience.
[2] F. López-Muñoz,et al. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents. , 2022, ACS pharmacology & translational science.
[3] L. Baer,et al. Differential Responses to Sigma-1 or Sigma-2 Receptor Ablation in Adiposity, Fat Oxidation, and Sexual Dimorphism , 2022, International journal of molecular sciences.
[4] M. Geva,et al. Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine , 2022, Autophagy.
[5] D. Zamanillo,et al. Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor. , 2022, ACS pharmacology & translational science.
[6] Ziyi Sun,et al. An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway , 2022, Nature Communications.
[7] H. Oki,et al. Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore. , 2022, Journal of medicinal chemistry.
[8] Steven B. Bradfute,et al. Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes , 2021, Cell.
[9] R. Mallik,et al. Mapping Sphingolipid Metabolism Pathways during Phagosomal Maturation. , 2021, ACS chemical biology.
[10] N. Ben-Tal,et al. The Sigma-1 receptor is an ER-localized type II membrane protein , 2021, The Journal of biological chemistry.
[11] M. Bhuiyan,et al. Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology , 2021, Frontiers in Physiology.
[12] M. Leopoldo,et al. Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives , 2021, International journal of molecular sciences.
[13] L. Salerno,et al. Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects , 2021, ACS chemical neuroscience.
[14] M. Hayden,et al. Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases , 2021, International journal of molecular sciences.
[15] T. Su,et al. Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain , 2021, Molecular Neurobiology.
[16] A. Pertovaara,et al. Spinal mechanisms contributing to the development of pain hypersensitivity induced by sphingolipids in the rat , 2021, Pharmacological Reports.
[17] I. Bezprozvanny,et al. The role of sigma-1 receptor in organization of endoplasmic reticulum signaling microdomains , 2020, bioRxiv.
[18] Na Ye,et al. Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. , 2020, Journal of medicinal chemistry.
[19] T. Maurice. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders , 2020, Expert opinion on drug discovery.
[20] Yolima P. Torres,et al. TRP Channels Role in Pain Associated With Neurodegenerative Diseases , 2020, Frontiers in Neuroscience.
[21] K. Stanford,et al. Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts. , 2020, Cellular signalling.
[22] Daniel A. Greenfield,et al. Virtual Screening for Ligand Discovery at the σ1 Receptor. , 2020, ACS medicinal chemistry letters.
[23] T. Tencomnao,et al. Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression , 2020, Scientific Reports.
[24] Giacomo Rossino,et al. New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative , 2019, J. Chem. Inf. Model..
[25] D. Schneider,et al. Lipid Binding Controls Dimerization of the Coat Protein p24 Transmembrane Helix. , 2019, Biophysical journal.
[26] G. Galdino,et al. The role of oligodendrocytes in chronic pain: cellular and molecular mechanisms. , 2019, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[27] I. Bezprozvanny,et al. Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases , 2019, Front. Neurosci..
[28] Lei Shi,et al. The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor , 2019, bioRxiv.
[29] H. Schmidt,et al. The Molecular Function of σ Receptors: Past, Present, and Future. , 2019, Trends in pharmacological sciences.
[30] Teruo Hayashi. The Sigma-1 Receptor in Cellular Stress Signaling , 2019, Front. Neurosci..
[31] W. Hong. Distinct regulation of sigma‐1 receptor multimerization by its agonists and antagonists , 2019, The FASEB Journal.
[32] Lian‐Wang Guo,et al. SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance , 2019, Autophagy.
[33] R. Klevit,et al. Mechanisms of Small Heat Shock Proteins. , 2019, Cold Spring Harbor perspectives in biology.
[34] Colin W. Taylor,et al. Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors , 2019, Cell reports.
[35] Liana C. Silva,et al. The role of ceramide in regulating endoplasmic reticulum function. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[36] K. Bollinger,et al. Sigma 1 receptor: A novel therapeutic target in retinal disease , 2018, Progress in Retinal and Eye Research.
[37] J. Buchner,et al. Small heat shock proteins: Simplicity meets complexity , 2018, The Journal of Biological Chemistry.
[38] P. Brust,et al. Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety. , 2018, Journal of medicinal chemistry.
[39] Ara M. Abramyan,et al. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays , 2018, Neuropharmacology.
[40] T. Tencomnao,et al. Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines , 2018, Neurotoxicity Research.
[41] M. Hiriart,et al. TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain , 2018, Proceedings of the National Academy of Sciences.
[42] M. B. Bauer,et al. Sigma‐1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors , 2017, Journal of neurochemistry.
[43] J. Yang,et al. APEX2- tagging of Sigma 1-receptor indicates subcellular protein topology with cytosolic N-terminus and ER luminal C-terminus , 2017, Protein & Cell.
[44] J. Yang,et al. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. , 2017, Oncotarget.
[45] S. Amara,et al. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats , 2017, The Journal of Biological Chemistry.
[46] E. Bieberich,et al. Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease , 2016, Journal of neuroscience research.
[47] S. Pyne,et al. Sphingosine Kinases: Emerging Structure-Function Insights. , 2016, Trends in biochemical sciences.
[48] H. Schmidt,et al. Crystal structure of the human σ1 receptor , 2016, Nature.
[49] Shang-Yi Tsai,et al. The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems. , 2016, Trends in pharmacological sciences.
[50] A. Bonci,et al. Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope , 2015, Proceedings of the National Academy of Sciences.
[51] Caroline H. Johnson,et al. Alterations in Spinal Cord Metabolism during Treatment of Neuropathic Pain , 2015, Journal of Neuroimmune Pharmacology.
[52] T. Su,et al. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid , 2015, Proceedings of the National Academy of Sciences.
[53] S. Spiegel,et al. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. , 2015, Experimental cell research.
[54] E. Sibille,et al. Sigma-1 and N-Methyl-D-Aspartate Receptors: A Partnership with Beneficial Outcomes , 2015, Molecular Neuropsychiatry.
[55] Deo R. Singh,et al. The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. , 2015, The Biochemical journal.
[56] G. Patti,et al. Inflammation triggers production of dimethylsphingosine from oligodendrocytes , 2014, Neuroscience.
[57] G. von Heijne,et al. Identification of novel sphingolipid-binding motifs in mammalian membrane proteins. , 2014, Biochimica et biophysica acta.
[58] C. Arenz,et al. Small Molecule Inhibitors of Ceramidases , 2014, Cellular Physiology and Biochemistry.
[59] B. Fox,et al. The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands , 2014, The Journal of Biological Chemistry.
[60] B. Brügger,et al. Sphingolipids as modulators of membrane proteins. , 2014, Biochimica et biophysica acta.
[61] Nidhi Kaushal,et al. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects. , 2014, Advances in pharmacology.
[62] J. Schnell,et al. Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions* , 2013, The Journal of Biological Chemistry.
[63] Jacques Fantini,et al. How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains , 2013, Front. Physiol..
[64] M. Kress,et al. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. , 2013, Trends in pharmacological sciences.
[65] D. Selley,et al. Sphingosine-1-phosphate receptors as emerging targets for treatment of pain. , 2012, Biochemical pharmacology.
[66] S. Kourrich,et al. The sigma-1 receptor: roles in neuronal plasticity and disease , 2012, Trends in Neurosciences.
[67] Alexander D. MacKerell,et al. Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing , 2012, J. Chem. Inf. Model..
[68] Teruo Hayashi,et al. The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones* , 2012, The Journal of Biological Chemistry.
[69] A. Hajipour,et al. The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. , 2012, Current pharmaceutical design.
[70] R. Pepperkok,et al. Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain , 2012, Nature.
[71] K. Oh-hashi,et al. Chloroquine inhibits glutamate‐induced death of a neuronal cell line by reducing reactive oxygen species through sigma‐1 receptor , 2011, Journal of neurochemistry.
[72] A. Hajipour,et al. Characterization of interactions of 4-nitrophenylpropyl-N-alkylamine with ς receptors. , 2011, Biochemistry.
[73] S. Safrany,et al. Antagonists show GTP‐sensitive high‐affinity binding to the sigma‐1 receptor , 2011, British journal of pharmacology.
[74] L. Obeid,et al. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[76] Tangui Maurice,et al. The pharmacology of sigma-1 receptors. , 2009, Pharmacology & therapeutics.
[77] Jianpeng Ma,et al. CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..
[78] S. Pyne,et al. The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. , 2009, European journal of pharmacology.
[79] M. Jackson,et al. The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.
[80] L. Obeid,et al. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. , 2008, Biochimica et biophysica acta.
[81] A. Hajipour,et al. Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. , 2008, Biochemistry.
[82] Yusuf A. Hannun,et al. Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.
[83] Y. Lee,et al. N,N-Dimethyl-D-erythro-sphingosine inhibits store-operated Ca2+ entry in U937 monocytes. , 2008, Journal of pharmacological sciences.
[84] Teruo Hayashi,et al. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.
[85] R. Chang,et al. In vitro and in vivo binding of neuroactive steroids to the sigma‐1 receptor as measured with the positron emission tomography radioligand [18F]FPS , 2007, Synapse.
[86] A. Ruoho,et al. Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. , 2007, Protein expression and purification.
[87] A. Hajipour,et al. Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. , 2007, Molecular pharmacology.
[88] L. Obeid,et al. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. , 2006, Biochimica et biophysica acta.
[89] T. Maurice,et al. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. , 2006, Journal of pharmacological sciences.
[90] G. Schultz,et al. Activation of the Melastatin-Related Cation Channel TRPM3 by d-erythro-Sphingosine , 2005, Molecular Pharmacology.
[91] Teruo Hayashi,et al. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[92] X. Codony,et al. Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.
[93] R. Schiffmann,et al. Glucosylceramide and Glucosylsphingosine Modulate Calcium Mobilization from Brain Microsomes via Different Mechanisms* , 2003, Journal of Biological Chemistry.
[94] Teruo Hayashi,et al. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.
[95] P. Casellas,et al. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. , 2001, Brain research. Molecular brain research.
[96] H. Nakayama,et al. (2R-trans)-2-butyl-5-heptylpyrrolidine as a potent sigma receptor ligand produced by Streptomyces longispororuber. , 2000, The Journal of antibiotics.
[97] E. Kempner,et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[98] A. Bielawska,et al. (1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of Ceramidase (*) , 1996, The Journal of Biological Chemistry.
[99] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[100] S. Hakomori,et al. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. , 1996, Biochemistry.
[101] W. Bowen,et al. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. , 1995, European journal of pharmacology.
[102] A. Ruoho,et al. (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[103] D. W. Parish,et al. Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. , 1991, The Journal of pharmacology and experimental therapeutics.
[104] T. Su,et al. Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes. , 1991, The Journal of pharmacology and experimental therapeutics.
[105] Y. Igarashi. Possible Roles of Sphingosine and N, N-Dimethylsphingosine as Modulators in Membrane Signal Transduction Systems , 1990 .
[106] Y. Igarashi,et al. A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. Demonstration of its endogenous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cells. , 1990, The Journal of biological chemistry.
[107] S. Hakomori,et al. Enzymatic synthesis of N,N-dimethyl-sphingosine: demonstration of the sphingosine: N-methyltransferase in mouse brain. , 1989, Biochemical and biophysical research communications.
[108] W. Bowen,et al. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors. , 1989, FEBS letters.
[109] E. London,et al. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.